FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917373755> ?p ?o ?g. }

• W2917373755 endingPage "398" @default.
• W2917373755 startingPage "392" @default.
• W2917373755 abstract "The edge vascular response (EVR) remains unknown in second generation drug-eluting Resorbable Magnesium Scaffold (RMS), such as Magmaris. The aim of the study was to evaluate tissue modifications in the RMS edges over time, assessed by different invasive imaging modalities.The patients treated with the device were assessed by optical coherence tomography (OCT), grayscale intravascular ultrasound (IVUS), and virtual histology IVUS at baseline and 12 months. The EVR study performed a segment- and frame-level analysis of the 5 mm segments proximal and distal of the actual RMS.The segment-level grayscale IVUS (n = 10), virtual histology IVUS (n = 10), and OCT (n = 18) analysis did not show any significant changes after 12 months, except for a fibrous plaque area (FPA) reduction of 0.5mm2 (p = 0.017) in the proximal segment compared to baseline. In the frame-level analysis, IVUS evaluation revealed a vessel area decreased 2.80 ± 1.43 mm2 (p = 0.012) and 2.49 ± 1.53 mm2 (p = 0.022) in 2 proximal frames. This was accompanied by plaque area reduction of 0.88 ± 0.70 mm2 (p = 0.048) and a FPA decreased by 0.63 ± 0.48 mm2 (p = 0.004) in one proximal frame. In 1 distal frame, there was a dense calcium area reduction of 0.10 ± 0.12 mm2 (p = 0.045), FPA and fibrous fatty plaque increased 0.54 ± 0.53 mm2 (p = 0.023) and 0.17 ± 0.16 mm2 (p = 0.016), respectively. By OCT, there was a lumen area decrease of 0.76 ± 1.51 mm2 (p = 0.045) in a distal frame.At 12 months, Magmaris EVR assessment does not show overall significant changes, except for a fibrous plaque area reduction in the proximal segment. This could be translated as a benign healing process at the edges of the RMS.The edge vascular response (EVR) remains unknown in second generation drug-eluting absorbable metal scaffolds (RMS), such as Magmaris. Patients treated with the device were assessed by multi invasive imaging modalities [i.e. optical coherence tomography (OCT), grayscale intravascular ultrasound (IVUS), and virtual histology IVUS] evaluating the tissue changes over time in the segment- and frame-level analysis of the 5 mm segments proximal and distal of the actual RMS. As a result, after 12 months, Magmaris EVR assessment does not show overall significant changes, except for a fibrous plaque area reduction in the proximal segment, translating a benign healing process at the edges of the RMS." @default.
• W2917373755 created "2019-03-02" @default.
• W2917373755 creator A5002279235 @default.
• W2917373755 creator A5003299152 @default.
• W2917373755 creator A5007579304 @default.
• W2917373755 creator A5010017598 @default.
• W2917373755 creator A5012980712 @default.
• W2917373755 creator A5014475532 @default.
• W2917373755 creator A5014743162 @default.
• W2917373755 creator A5039719141 @default.
• W2917373755 creator A5054210556 @default.
• W2917373755 creator A5056349768 @default.
• W2917373755 creator A5059651131 @default.
• W2917373755 creator A5060774728 @default.
• W2917373755 creator A5062318295 @default.
• W2917373755 creator A5076940448 @default.
• W2917373755 creator A5077653018 @default.
• W2917373755 creator A5078216260 @default.
• W2917373755 creator A5080359871 @default.
• W2917373755 creator A5083727386 @default.
• W2917373755 creator A5083922631 @default.
• W2917373755 creator A5085730167 @default.
• W2917373755 creator A5090928821 @default.
• W2917373755 date "2019-05-01" @default.
• W2917373755 modified "2023-10-18" @default.
• W2917373755 title "First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study" @default.
• W2917373755 cites W122385609 @default.
• W2917373755 cites W1584934405 @default.
• W2917373755 cites W168190192 @default.
• W2917373755 cites W1911838187 @default.
• W2917373755 cites W1956305767 @default.
• W2917373755 cites W1967643593 @default.
• W2917373755 cites W1977998724 @default.
• W2917373755 cites W1993222177 @default.
• W2917373755 cites W1998004031 @default.
• W2917373755 cites W2026168678 @default.
• W2917373755 cites W2054783224 @default.
• W2917373755 cites W2079818105 @default.
• W2917373755 cites W2090617135 @default.
• W2917373755 cites W2110100816 @default.
• W2917373755 cites W2153535413 @default.
• W2917373755 cites W2165441306 @default.
• W2917373755 cites W2165754633 @default.
• W2917373755 cites W2401593360 @default.
• W2917373755 cites W2412291070 @default.
• W2917373755 cites W2528269819 @default.
• W2917373755 cites W2606322438 @default.
• W2917373755 cites W2766646907 @default.
• W2917373755 cites W2766668643 @default.
• W2917373755 cites W2776747056 @default.
• W2917373755 cites W3149209040 @default.
• W2917373755 doi "https://doi.org/10.1016/j.carrev.2019.02.019" @default.
• W2917373755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31079817" @default.
• W2917373755 hasPublicationYear "2019" @default.
• W2917373755 type Work @default.
• W2917373755 sameAs 2917373755 @default.
• W2917373755 citedByCount "9" @default.
• W2917373755 countsByYear W29173737552019 @default.
• W2917373755 countsByYear W29173737552020 @default.
• W2917373755 countsByYear W29173737552021 @default.
• W2917373755 countsByYear W29173737552022 @default.
• W2917373755 crossrefType "journal-article" @default.
• W2917373755 hasAuthorship W2917373755A5002279235 @default.
• W2917373755 hasAuthorship W2917373755A5003299152 @default.
• W2917373755 hasAuthorship W2917373755A5007579304 @default.
• W2917373755 hasAuthorship W2917373755A5010017598 @default.
• W2917373755 hasAuthorship W2917373755A5012980712 @default.
• W2917373755 hasAuthorship W2917373755A5014475532 @default.
• W2917373755 hasAuthorship W2917373755A5014743162 @default.
• W2917373755 hasAuthorship W2917373755A5039719141 @default.
• W2917373755 hasAuthorship W2917373755A5054210556 @default.
• W2917373755 hasAuthorship W2917373755A5056349768 @default.
• W2917373755 hasAuthorship W2917373755A5059651131 @default.
• W2917373755 hasAuthorship W2917373755A5060774728 @default.
• W2917373755 hasAuthorship W2917373755A5062318295 @default.
• W2917373755 hasAuthorship W2917373755A5076940448 @default.
• W2917373755 hasAuthorship W2917373755A5077653018 @default.
• W2917373755 hasAuthorship W2917373755A5078216260 @default.
• W2917373755 hasAuthorship W2917373755A5080359871 @default.
• W2917373755 hasAuthorship W2917373755A5083727386 @default.
• W2917373755 hasAuthorship W2917373755A5083922631 @default.
• W2917373755 hasAuthorship W2917373755A5085730167 @default.
• W2917373755 hasAuthorship W2917373755A5090928821 @default.
• W2917373755 hasConcept C120665830 @default.
• W2917373755 hasConcept C121332964 @default.
• W2917373755 hasConcept C126838900 @default.
• W2917373755 hasConcept C131631996 @default.
• W2917373755 hasConcept C136229726 @default.
• W2917373755 hasConcept C141071460 @default.
• W2917373755 hasConcept C142724271 @default.
• W2917373755 hasConcept C143753070 @default.
• W2917373755 hasConcept C160633673 @default.
• W2917373755 hasConcept C2776931568 @default.
• W2917373755 hasConcept C2778818243 @default.
• W2917373755 hasConcept C2989005 @default.
• W2917373755 hasConcept C57742111 @default.
• W2917373755 hasConcept C71924100 @default.
• W2917373755 hasConcept C78201319 @default.

• next